← Leaderboards
P. Hemachandra Reddy
Oregon Health And Science University
$15,216,000
Attributed
$15,216,000
Total exposure
20
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2007–23$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$15,216,000 · 20
By mechanism
R01$10,642,029 · 5
RF1$1,862,337 · 1
R56$1,857,014 · 3
P51$529,613 · 9
R41$249,507 · 1
R03$75,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Linda J. Kenney$2,770,114
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMitochondriaBrainNeuronsAutopsyDisease ProgressionProteinsWild Type MouseBaseAmyloid Beta-ProteinS DiseaseProductionToxic EffectAffectMitochondrial DysfunctionMutantPreventSynapsesTransgenic MiceResearch PersonnelPathogenesisPathologyGenesBehavior
Grant awards (43)
Mitochondrial Molecules as Therapeutic Drugs for Alzheimer's Disease$651,088
R01 · FY2023 · AG · contact PI
RLIP, Mitochondrial Dysfunction in Alzheimerâs Disease$572,035
R56 · FY2023 · AG · contact PI
Mitochondrial Molecules in Alzheimer's Disease and Other Tauopathies$382,050
R01 · FY2023 · AG · contact PI
MicroRNA Mouse Models and Alzheimerâs Disease$1,862,337
RF1 · FY2022 · AG · contact PI
Mitochondrial Molecules as Therapeutic Drugs for Alzheimer's Disease$651,088
R01 · FY2022 · AG · contact PI
Mitochondrial Molecules and Alzheimer's Disease$382,486
R01 · FY2022 · AG · contact PI
Mitochondrial Molecules as Therapeutic Drugs for Alzheimer's Disease$651,088
R01 · FY2021 · AG · contact PI
Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease$318,653
R01 · FY2021 · NS · contact PI
Mitochondrial Molecules as Therapeutic Drugs for Alzheimer's Disease$651,088
R01 · FY2020 · AG · contact PI
MicroRNA-455-3p and Alzheimer's Disease$585,734
R56 · FY2020 · AG · contact PI
Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease$378,271
R01 · FY2020 · NS · contact PI
Small Molecules as Therapeutic Targets for Alzheimer's Disease$699,245
R56 · FY2019 · AG · contact PI
Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease$378,271
R01 · FY2019 · NS · contact PI
Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease$378,271
R01 · FY2018 · NS · contact PI
Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease$373,887
R01 · FY2018 · AG · contact PI
Small Molecule Inhibitor Therapeutic Target for Alzheimer's Disease.$249,507
R41 · FY2018 · AG · contact PI
Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease$378,271
R01 · FY2017 · NS · contact PI
Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease$373,887
R01 · FY2017 · AG · contact PI
Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease$373,887
R01 · FY2016 · AG · contact PI
Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease$340,798
R01 · FY2016 · AG · contact PI
Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease$365,294
R01 · FY2015 · AG · contact PI
Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease$362,669
R01 · FY2015 · AG · contact PI
Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease$392,803
R01 · FY2014 · AG · contact PI
Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease$336,377
R01 · FY2014 · AG · contact PI
Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease$101,958
R01 · FY2014 · AG · contact PI
Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease$43,645
R01 · FY2014 · AG · contact PI
Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease$412,444
R01 · FY2013 · AG · contact PI
Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease$439,653
R01 · FY2012 · AG · contact PI
Abeta Toxicity, ROS and Mitochondrial Dysfunction in Aging/Alzheimer's Disease$294,408
R01 · FY2011 · AG · contact PI
ABETA TOXICITY, ROS AND MITOCHONDRIAL DYSFUNCTION IN AGING/ALZHEIMER'S DISEASE$58,239
P51 · FY2011 · RR · contact PI
NEUROPROTECTION AND ALZHEIMER'S DISEASE$43,647
P51 · FY2011 · RR · contact PI
NEUROPROTECTIVE EFFECTS OF DIMEBON IN ALZHEIMER'S DISEASE$43,647
P51 · FY2011 · RR · contact PI
MITOCHONDRIAL TARGETED ANTIOXIDANT THERAPEUTICS IN MULTIPLE SCLEROSIS$36,286
P51 · FY2011 · RR · contact PI
Abeta Toxicity, ROS and Mitochondrial Dysfunction in Aging/Alzheimer's Disease$306,292
R01 · FY2010 · AG · contact PI
ABETA TOXICITY, ROS AND MITOCHONDRIAL DYSFUNCTION IN AGING/ALZHEIMER'S DISEASE$76,080
P51 · FY2010 · RR · contact PI
NEUROPROTECTION AND ALZHEIMER'S DISEASE$57,095
P51 · FY2010 · RR · contact PI
NEUROPROTECTIVE EFFECTS OF DIMEBON IN ALZHEIMER'S DISEASE$57,095
P51 · FY2010 · RR · contact PI
MITOCHONDRIAL TARGETED ANTIOXIDANT THERAPEUTICS IN MULTIPLE SCLEROSIS$57,095
P51 · FY2010 · RR · contact PI
Abeta Toxicity, ROS and Mitochondrial Dysfunction in Aging/Alzheimer's Disease$309,386
R01 · FY2009 · AG · contact PI
ABETA TOXICITY, ROS AND MITOCHONDRIAL DYSFUNCTION IN AGING/ALZHEIMER'S DISEASE$100,429
P51 · FY2009 · RR · contact PI
Abeta Toxicity, ROS and Mitochondrial Dysfunction in Aging/Alzheimer's Disease$309,386
R01 · FY2008 · AG · contact PI
Abeta Toxicity, ROS and Mitochondrial Dysfunction in Aging/Alzheimer's Disease$304,630
R01 · FY2007 · AG · contact PI
Microarrays for Alzheimer's Disease Mouse Models$75,500
R03 · FY2003 · AG